FDA 483 - Tianjin Institute of Pharmaceutical Research New Drug Evaluation Co. Ltd - May 19, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Tianjin Institute of Pharmaceutical Res. New Drug Eval. Co., Ltd, a nonclinical laboratory, revealed significant deficiencies across multiple areas. Observations included inadequate cleaning and sanitation of animal housing, poor facility maintenance, and failures in retaining reserve samples. Additionally, issues were noted with equipment maintenance records, accurate data recording, and adherence to standard operating procedures and study protocols.
- Inspection Date
- May 19, 2025
- Product Type
- Drugs
ID · 9d4734df-d95f-447f-a2ae-4c55e3e2caca